recent articles
April 05, 2015
Accuracy of HER2 Testing in Gastric Cancer
- Anatomic Pathology
- Business
- Clinical Laboratories
- Current Affairs
- Device Manufacturers
- Digital Pathology News
- Education
- File format
- Genetics
- Histology
- Image Analysis
- Informatics
- International
- Laboratory Compliance
- Laboratory Informatics
- Medical Research
- Pathology News
- Patient Advocacy
- Science
- Standards and Guidelines
- Training
- Vendor products
- Web/Tech
- Webinars
- Whole slide
With almost 1 million new cases per year, gastric cancer is currently the number four most common malignant disease. Today, there is no universal standard treatment. Recently, however, the ToGA trial demonstrated efficacy of Trastuzumab...
Join Visiopharm for our webinar, “HER2 Protein Expression in Breast Cancer: Membrane Morphology and Accuracy with Regard to Gene Amplification” presented by Michael Grunkin, PhD the CEO and co-founder of Visiopharm. Date: Monday,...
Join Visiopharm for our webinar, “HER2 Protein Expression in Breast Cancer: Membrane Morphology and Accuracy with Regard to Gene Amplification” presented by Michael Grunkin, PhD the CEO and co-founder of Visiopharm. Date: Monday,...
© 2023 Tissuepathology.com. All rights reserved. Millennial Consulting. | Web Design by Zealth Digital Marketing